Showing results (171-180 of 506) with videos related to
Sort By:
Pageof 51
Plos One|June 16, 2016
Dabigatran and Argatroban Diametrically Modulate Thrombin Exosite FunctionCalvin H Yeh, Alan R Stafford, Beverly A Leslie, et al.The Journal of Biological Chemistry|December 22, 2011
A high affinity interaction of plasminogen with fibrin is not essential for efficient activation by tissue-type plasminogen activatorPaul Y Kim, Long D Tieu, Alan R Stafford, et al.Thrombosis and Haemostasis|April 21, 2019
Factor XIII Prevents Pulmonary Emboli in Mice by Stabilizing Deep Vein ThrombiShana A Shaya, Dhulfiha Muzafar Gani, Jeffrey I Weitz, et al.Research and Practice in Thrombosis and Haemostasis|January 23, 2018
Activity of Factor XII-LocarnoBassem M Mohammed, Ivan Ivanov, Anton Matafonov, et al.The Journal of Biological Chemistry|December 26, 2001
Characterization of the H-kininogen-binding site on factor XI: a comparison of factor XI and plasma prekallikreinThomas Renné, David Gailani, Joost C M Meijers, et al.Anesthesiology|November 26, 2003
Tissue factor and platelet glycoprotein Ib-alpha alleles are associated with age at first coronary bypass operationBrian S Donahue, Daniel W Byrne, David Gailani, et al.The Journal of Biological Chemistry|August 20, 2004
Identification of a binding site for glycoprotein Ibalpha in the Apple 3 domain of factor XIFrank A Baglia, David Gailani, José A López, et al.Blood Reviews|August 5, 2018
Plasma contact factors as therapeutic targetsBenjamin F Tillman, Andras Gruber, Owen J T McCarty, et al.Chest|September 24, 2004
Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic TherapyJeffrey J Popma, Peter Berger, E Magnus Ohman, et al.Circulation|April 30, 2019
Combination Antiplatelet and Oral Anticoagulant Therapy in Patients With Coronary and Peripheral Artery DiseasePaul A Gurbel, Keith A A Fox, Udaya S Tantry, et al.Pageof 51